New commercial opportunity for PBT2
 |
MELBOURNE, Australia, Dec. 22, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced it has been granted a licence by UniQuest, the commercialisation company of The University of Queensland (UQ), to novel zinc ionophore technology to combat...
Every four years, the FIFA World Cup becomes one of the largest commercial events on Earth. Billions of people watch match...
The latest job reductions at Nine Entertainment have again highlighted a question confronting every modern publisher. Can ...
Many Australians have encountered a familiar message while reading the news online. "Subscribe to continue reading." Whet...
When SpaceX first landed a Falcon 9 booster vertically on a floating drone ship, many experts desc...
Fremantle Ports has partnered with Byssal and DevelopmentWA to trial an innovative nature-based pilo...
After years of changing food trends—from low-fat to low-carbohydrate, detoxes and "superfoods"—it ...
The Korea Tourism Organization (KTO) has launched Korea Unlocks More of You, a new national campai...
Reel Rock 20 returns to Australian and New Zealand screens this November as a part of the Reel Roc...
The Korea Tourism Organization (KTO) has launched Korea Unlocks More of You, a new national campai...
Immigration has long helped shape modern Australia. New arrivals have contributed to the nation's...